Bret L. Bostwick
InvestorVenture Advisor at Breyer Capital
About
Bret Bostwick is a physician-scientist and drug developer with experience in drug discovery and translational medicine, currently at Alnylam Pharmaceuticals. He leads the advisory firm Translational Medicine Solutions at the intersection of healthcare, technology, and venture capital.
Colleagues at Breyer Capital
Daniel Breyer
Investor and founder in San Francisco
George Sard
Investor at Breyer Capital
Jim Breyer
Founder & CEO of Breyer Capital
Leo Grady
CEO in Residence - Founder/CEO of Jona Health at Breyer Capital
Morgan Cheatham
Partner and Head of Healthcare and Life Sciences at Breyer Capital
Samuel J. Palmisano
Venture Advisor at Breyer Capital
Sophia Sun Zou
Partner at Breyer Capital
Ted Breyer
Partner at Breyer Capital
Frequently asked questions
- Who is Bret L. Bostwick?
- Bret Bostwick is a physician-scientist and drug developer with experience in drug discovery and translational medicine, currently at Alnylam Pharmaceuticals. He leads the advisory firm Translational Medicine Solutions at the intersection of healthcare, technology, and venture capital.
- Where does Bret L. Bostwick work?
- Bret L. Bostwick is Venture Advisor at Breyer Capital.